HALOZYME, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 55200
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 26141
 
  
 
C07K PEPTIDES 10126
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 7199
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 643
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 594
 
  
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 2152
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 297
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 2123
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0044,419 COMBINATION THERAPY WITH A HYALURONAN-DEGRADING ENZYME AND AN IMMUNE CHECKPOINT INHIBITORFeb 27, 17Feb 15, 18[A61K, C07K]
2016/0362,670 PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOFAug 02, 16Dec 15, 16[C12N]
2015/0165,059 SOLUBLE GLYCOSAMINOGLYCANASES AND METHODS OF PREPARING AND USING SOLUBLE GLYCOSAMINOGLYCANASESFeb 20, 15Jun 18, 15[A61K, C12N]
2013/0028,856 Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditionsFeb 22, 12Jan 31, 13[A61K, C12Q, G01N, A61P]
2013/0022,592 Continuous subcutaneous insulin infusion methods with a hyaluronan-degrading enzymeJun 15, 12Jan 24, 13[A61K, A61P, A61M]
2013/0011,378 Stable formulations of a hyaluronan-degrading enzymeJun 15, 12Jan 10, 13[A61K, A61P]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9913822 Combination therapy with an anti-hyaluronan agent and therapeutic agentMar 15, 13Mar 13, 18[A61K, C12N]
9878046 Adverse side-effects associated with administration of an anti-hyaluronan agent and methods for ameliorating or preventing the side-effectsJul 15, 11Jan 30, 18[A61K]
9833498 Methods of treatment of collagen-mediated diseases and conditionsMar 06, 09Dec 05, 17[A61K, C12N]
9775889 Methods of treatment of celluliteApr 02, 14Oct 03, 17[A61K, C12N]
9683985 Methods for assessing and identifying or evolving conditionally active therapeutic proteinsSep 27, 11Jun 20, 17[G01N, C07K]
9677061 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereofDec 21, 10Jun 13, 17[A61K, C12N]
9677062 Hyaluronidase and factor VIII compositionsDec 28, 11Jun 13, 17[A61K, C12N]
9562223 Methods for reducing intraocular pressure by administering a soluble hyaluronidase glycoprotein (sHASEGP)Feb 26, 14Feb 07, 17[A61K, C12N]
9458442 Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereofAug 14, 14Oct 04, 16[A61K, C12N, G01N, C07K]
9447401 PH20 polypeptide variants, formulations and uses thereofDec 28, 12Sep 20, 16[A61K, C12Q, C12N]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2015/0196,625 Metal Sensitive Mutants of Matrix Metalloproteases and uses thereofAbandonedJan 07, 14Jul 16, 15[A61K]
2015/0071,923 MODIFIED ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODIES AND METHODS OF USE THEREOFAbandonedSep 12, 14Mar 12, 15[A61K, C07K]
2015/0010,529 THERMALLY STABLE PH20 HYALURONIDASE VARIANTS AND USES THEREOFAbandonedJul 03, 14Jan 08, 15[A61K, C12Q, C12N]
2014/0350,087 Oncovector Nucleic Acid Molecules and Methods of UseAbandonedMar 13, 13Nov 27, 14[A61K, C12N]
2014/0341,875 Human chondroitinase glycoprotein (CHASEGP), process for preparing the same, and pharmaceutical compositions comprising thereofAbandonedJul 16, 14Nov 20, 14[C12N]
2014/0170,159 Conditionally active anti-epidermal growth factor receptor antibodies and methods of use thereofAbandonedMar 08, 13Jun 19, 14[C07K]
2014/0037,613 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanasesAbandonedSep 25, 13Feb 06, 14[A61K]
8551071 Gas-pressured medication delivery deviceExpiredMar 18, 11Oct 08, 13[A61M]
2011/0229,451 TEMPERATURE SENSITIVE MUTANTS OF MATRIX METALLOPROTEASES AND USES THEREOFAbandonedMar 05, 10Sep 22, 11[A61K, C07H, C12N, A61P]
2011/0212,074 Myeloid colony stimulating factor and uses thereofAbandonedApr 29, 11Sep 01, 11[A61K, A61P]
2010/0331,279 Inhibition of Antigen Presentation with Poorly Catabolized PolymersAbandonedAug 31, 10Dec 30, 10[A61K]
2010/0184,845 Myeloid Colony Stimulating Factor and Uses ThereofAbandonedApr 01, 10Jul 22, 10[A61K, C07H, C12N]
2010/0130,958 Device and Methods for Subcutaneous Delivery of High Viscosity FluidsAbandonedNov 26, 08May 27, 10[A61M]
2010/0003,238 Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditionsAbandonedApr 14, 09Jan 07, 10[A61K, A61P]
2009/0311,237 Combination therapy using a soluble hyaluronidase and a bisphosphonateAbandonedApr 14, 09Dec 17, 09[A61K]
7538097 Inhibition of antigen presentation with poorly catabolized polymersExpiredSep 25, 01May 26, 09[A61K]
2006/0104,968 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanasesAbandonedSep 27, 05May 18, 06[A61K, C12N]
6682904 Specific inhibitors of hyaluronidase 2, and methods of identifying and using sameExpiredAug 15, 02Jan 27, 04[C12Q, C12N]
2003/0212,021 Myeloid colony stimulating factor and uses thereofAbandonedNov 26, 02Nov 13, 03[A61K, C12N]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.